Seelos Therapeutics Inc (SEEL)
0.301
-0.03
(-7.98%)
USD |
NASDAQ |
Apr 24, 16:00
0.3012
0.00 (0.00%)
Pre-Market: 20:00
Seelos Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2023 | -1.56K% |
December 31, 2022 | |
September 30, 2022 | |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 |
Date | Value |
---|---|
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | -88.70% |
September 30, 2015 | -395.4% |
June 30, 2015 | -1.14K% |
March 31, 2015 | -1.35K% |
December 31, 2014 | -906.6% |
September 30, 2014 | -164.0% |
June 30, 2014 | 34.42% |
March 31, 2014 | |
December 31, 2013 | -371.5% |
September 30, 2013 | -10.66K% |
June 30, 2013 | -330.1% |
March 31, 2013 | -933.6% |
December 31, 2012 | -826.1% |
September 30, 2012 | -50.95% |
June 30, 2012 | -164.2K% |
March 31, 2012 | -603.5% |
December 31, 2011 | |
September 30, 2011 | -277.8% |
June 30, 2011 | -488.6% |
March 31, 2011 | -214.9% |
December 31, 2010 | -1.29K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.56K%
Minimum
Mar 2023
-1.56K%
Maximum
Mar 2023
-1.56K%
Average
-1.56K%
Median
Mar 2023
Profit Margin (Quarterly) Benchmarks
180 Life Sciences Corp | -- |
Acurx Pharmaceuticals Inc | -- |
NovaBay Pharmaceuticals Inc | -110.2% |
Palatin Technologies Inc | -385.6% |
iBio Inc | -- |